Imara Competitors and Similar CompaniesClear all
Imara's competitors and similar companies include Cassava Sciences, ReViral and Sorriso Pharmaceuticals.
 Imara Imara is a company, dedicated to developing novel therapeutics for people living with sickle cell disease and other hemoglobinopathies. |  Cassava Sciences Cassava Sciences (formerly known as Pain Therapeutics) is a clinical-stage biotechnology company that specializes in drug development. |  Sorriso Pharmaceuticals Sorriso Pharmaceuticals is a company developing a therapy platform that provides a pipeline of disease-modifying antibodies to treat inflammatory diseases. | ||
Founding Date | Founding Date 2015 | Founding Date 1998 | Founding Date 2011 | Founding Date 2020 |
Type | Type Public | Type Public | Type Private | Type Private |
Tags | ||||
Locations | Locations Boston, US HQ | Locations Austin, US HQ | Locations Stevenage, GB HQ Durham, US | Locations HQ |
Employees | Employees 20 | Employees 2912% increase | Employees 5 | Employees N/A |
Valuation ($) | Valuation ($) 166.1 m | Valuation ($) 1.3 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | ||||
Net income | Net income ($89m) (FY, 2024) | Net income ($24.3m) (FY, 2024) | Net income N/A | Net income N/A |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 44m (almost 5 years ago) | Latest funding round $ 31m (over 3 years ago) |
Total funding raised | Total funding raised $ 94m | Total funding raised N/A | Total funding raised $ 121m | Total funding raised $ 31m |
For sources of this data, please see the company profile
View Company Profiles
Cassava Sciences
HQ
Austin, US
Employees
29↑ 12% increase
Cassava Sciences (formerly known as Pain Therapeutics) is a clinical-stage biotechnology company that specializes in drug development.
View company
ReViral
HQ
Stevenage, GB
Employees
5
ReViral is a biotechnology company developing drugs to treat RSV infections.
View companySorriso Pharmaceuticals
HQ
Sorriso Pharmaceuticals is a company developing a therapy platform that provides a pipeline of disease-modifying antibodies to treat inflammatory diseases.
View company